Bernard J. Zovighian, CEO at Edwards Lifesciences Corp (EW), sold 15,548 shares at $74.91 ($977K) on 2025-05-05, disclosed to the SEC on 2025-05-06.
Scheduled sale ($977k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.65 | 527 | $40K | 4.1% |
| 2 | $75.65 | 543 | $41K | 4.2% |
| 3 | $0.00 | 1,482 | $0 | 0.0% |
| 4 | $74.91 | 5,980 | $448K | 45.9% |
| 5 | $74.91 | 5,980 | $448K | 45.9% |
| 6 | $0.00 | 1,036 |
| $0 |
| 0.0% |
| Total | $62.83 avg | 15,548 | $977K | 100% |
| Filing → |
| EW | SELL | 2026-05-12 | $2.8M | — | Filing → |
| EW | SELL | 2026-02-13 | $3.4M | — | Filing → |
| EW | SELL | 2025-12-10 | $4.3M | — | Filing → |